Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-01 Purchase |
2021-12-10 6:50 pm |
Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner |
185,941 | $1.66 | $308,662 | 0 (Indirect) |
View |
| 2021-12-01 Sale |
2021-12-10 6:50 pm |
Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner |
5,887,610 | $1.6545 | $9,741,063 | 0 (Indirect) |
View |
| 2021-11-22 Sale |
2021-11-24 6:00 pm |
Odonate Therapeutics Inc. | ODT | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH 10% Owner |
400,000 | $1.5583 | $623,340 | 4,207,086 (Direct) |
View |
| 2021-11-17 Sale |
2021-11-19 7:22 pm |
Odonate Therapeutics Inc. | ODT | Davis Aaron I. Director 10% Owner |
1,200,000 | $2.0833 | $2,499,948 | 5,052,842 (Indirect Direct) |
View |
| 2021-11-17 Sale |
2021-11-19 7:21 pm |
Odonate Therapeutics Inc. | ODT | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Director 10% Owner |
1,000,000 | $2.0628 | $2,062,775 | 4,607,086 (Direct) |
View |
| 2021-11-17 Sale |
2021-11-19 4:38 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner |
2,747,131 | $2.086 | $5,730,557 | 12,767,435 (Indirect) |
View |
| 2020-12-29 Purchase |
2020-12-31 4:01 pm |
Odonate Therapeutics Inc. | ODT | Johnson Craig A Director |
3,000 | $17 | $51,000 | 3,000 (Direct) |
View |
| 2020-12-28 Purchase |
2020-12-30 6:19 pm |
Odonate Therapeutics Inc. | ODT | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH Director 10% Owner |
400,000 | $17.16 | $6,863,428 | 5,607,086 (Direct) |
View |
| 2020-12-28 Purchase |
2020-12-30 6:18 pm |
Odonate Therapeutics Inc. | ODT | Davis Aaron I. Director 10% Owner |
400,000 | $17.16 | $6,863,428 | 6,252,842 (Indirect Direct) |
View |
| 2020-12-21 Purchase |
2020-12-23 4:41 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Hearne Michael S Chief Executive Officer 10% Owner |
275,784 | $15.16 | $4,181,208 | 15,514,566 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-11-18 1:00 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | EcoR1 Capital LLC 10% Owner |
0 | $0 | 5,701,669 (Indirect) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
37 | $16.22 | 15,517,223 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:04 pm |
N/A 2031-03-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
37 | $0 | 15,517,223 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
99 | $16.22 | 3,709 (Direct) |
View |
| 2021-03-15 Option Award |
2021-03-17 4:04 pm |
N/A 2031-03-15 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
99 | $0 | 3,709 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:03 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
34 | $17.89 | 15,517,183 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:03 pm |
N/A 2031-02-26 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
34 | $0 | 15,517,183 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:02 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
90 | $17.89 | 3,601 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 4:02 pm |
N/A 2031-02-26 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
90 | $0 | 3,601 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 4:07 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
28 | $21.19 | 15,517,143 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 4:07 pm |
N/A 2031-02-12 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
28 | $0 | 15,517,143 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
76 | $21.19 | 3,497 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 4:06 pm |
N/A 2031-02-12 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
76 | $0 | 3,497 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 4:10 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
31 | $19.64 | 15,517,118 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 4:10 pm |
N/A 2031-01-29 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
31 | $0 | 15,517,118 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 4:09 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
82 | $19.64 | 3,427 (Direct) |
View |
| 2021-01-29 Option Award |
2021-02-02 4:09 pm |
N/A 2031-01-29 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
82 | $0 | 3,427 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
35 | $16.99 | 15,517,091 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:01 pm |
N/A 2031-01-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
35 | $0 | 15,517,091 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
94 | $16.99 | 3,357 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 4:01 pm |
N/A 2031-01-15 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
94 | $0 | 3,357 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
350 | $16.32 | 15,517,371 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:06 pm |
N/A 2030-12-31 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
350 | $0 | 15,517,371 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
169 | $16.32 | 3,338 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 4:04 pm |
N/A 2030-12-31 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
169 | $0 | 3,338 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
43 | $12.91 | 15,240,930 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:01 pm |
N/A 2030-12-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
43 | $0 | 15,240,930 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
121 | $12.91 | 3,121 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:01 pm |
N/A 2030-12-15 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
121 | $0 | 3,121 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-10 4:06 pm |
N/A 2030-12-08 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
22,639 | $0 | 22,639 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-10 4:06 pm |
N/A 2030-12-08 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
60,373 | $0 | 60,373 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-10 4:05 pm |
N/A 2030-12-08 |
Odonate Therapeutics Inc. | ODT | Johnson Laura L. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-10 4:04 pm |
N/A 2030-12-08 |
Odonate Therapeutics Inc. | ODT | Rosen Robert Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-10 4:04 pm |
N/A 2030-12-08 |
Odonate Therapeutics Inc. | ODT | Johnson Craig A Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:02 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
45 | $12.77 | 15,240,889 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:02 pm |
N/A 2030-11-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
45 | $0 | 15,240,889 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:02 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
122 | $12.77 | 3,001 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:02 pm |
N/A 2030-11-30 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
122 | $0 | 3,001 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Lemkey John G Chief Operating Officer |
12 | $12.77 | 15,242,251 (Direct) |
View |
| 2020-11-30 Option Award |
2020-12-02 4:01 pm |
N/A 2030-11-30 |
Odonate Therapeutics Inc. | ODT | Lemkey John G Chief Operating Officer |
12 | $0 | 15,242,251 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $12.2 | 15,240,845 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:06 pm |
N/A 2030-11-13 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $0 | 15,240,845 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
128 | $12.2 | 2,885 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:06 pm |
N/A 2030-11-13 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
128 | $0 | 2,885 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Lemkey John G Chief Operating Officer |
96 | $12.2 | 15,242,323 (Direct) |
View |
| 2020-11-13 Option Award |
2020-11-17 4:04 pm |
N/A 2030-11-13 |
Odonate Therapeutics Inc. | ODT | Lemkey John G Chief Operating Officer |
96 | $0 | 15,242,323 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $12.25 | 15,240,799 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:06 pm |
N/A 2030-10-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
46 | $0 | 15,240,799 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:06 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
127 | $12.25 | 2,756 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:06 pm |
N/A 2030-10-30 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
127 | $0 | 2,756 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:05 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Lemkey John G Chief Operating Officer |
96 | $12.25 | 15,242,227 (Direct) |
View |
| 2020-10-30 Option Award |
2020-11-03 4:05 pm |
N/A 2030-10-30 |
Odonate Therapeutics Inc. | ODT | Lemkey John G Chief Operating Officer |
96 | $0 | 15,242,227 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
42 | $13.35 | 15,240,749 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:04 pm |
N/A 2030-10-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S Chief Financial Officer |
42 | $0 | 15,240,749 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:01 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
117 | $13.35 | 2,619 (Direct) |
View |
| 2020-10-15 Option Award |
2020-10-19 4:01 pm |
N/A 2030-10-15 |
Odonate Therapeutics Inc. | ODT | O'Connell Joseph P Chief Medical Officer |
117 | $0 | 2,619 (Direct) |
View |